The Patent Finder

Genmab A/S

Also on record
Records under this name other than the patents Genmab A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 87 patents it holds.

Back to Genmab A/S

PatentTitleStatus Expires Confidence
US 10,457,735Methods of Inducing T Cell Activation by Administering an Antibody Comprising CD40 and 4-1BB (CD137) Binding Domains
now held by BioNTech SE
In force
 · High confidence
In forceHigh confidence
US 10,927,181Agonistic Tumor Necrosis Factor (TNF) Receptor Binding Agents
now held by BioNTech SE
In force
 · High confidence
In forceHigh confidence
US 11,814,411Nucleic Acid Molecules Encoding Binding Agents to CD40 and 4-1BB (CD137)
now held by BioNTech SE
In force
 · High confidence
In forceHigh confidence
US 10,364,285Agents, Uses and Methods for the Treatment of Synucleinopathy
conveyed to H. Lundbeck A/S
In force
 · High confidence
In forceHigh confidence
US 10,428,147Anti-Sortilin Antibodies, Uses and Methods for Treatment
conveyed to H. Lundbeck A/S
In force
 · High confidence
In forceHigh confidence
US 10,479,835Agent, Uses and Methods for Treatment
conveyed to H. Lundbeck A/S
In force
 · High confidence
In forceHigh confidence
US 10,640,554Agents, Uses and Methods for the Treatment of Synucleinopathy
conveyed to H. Lundbeck A/S
In force
 · High confidence
In forceHigh confidence
US 10,647,763Agents, Uses and Methods for the Treatment of Synucleinopathy
conveyed to H. Lundbeck A/S
In force
 · High confidence
In forceHigh confidence
US 10,647,764Agents, Uses and Methods for the Treatment of Synucleinopathy
conveyed to H. Lundbeck A/S
In force
 · High confidence
In forceHigh confidence
US 10,800,836Agents, Uses and Methods for the Treatment of Synucleinopathy
conveyed to H. Lundbeck A/S
In force
 · High confidence
In forceHigh confidence
10 of 242 records shown.
Pro members see all 242.
Pro members: see all 242 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited